dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Minnai, Francesca |
dc.contributor.author | Biscarini, Filippo |
dc.contributor.author | Esposito, Martina |
dc.contributor.author | Dragani, Tommaso A. |
dc.contributor.author | Rahmouni, Souad |
dc.contributor.author | Bujanda, Luis |
dc.contributor.author | Buti Ferret, Maria |
dc.date.accessioned | 2024-02-19T13:29:53Z |
dc.date.available | 2024-02-19T13:29:53Z |
dc.date.issued | 2024-02-06 |
dc.identifier.citation | Minnai F, Biscarini F, Esposito M, Dragani TA, Bujanda L, Rahmouni S, et al. A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death. Sci Rep. 2024 Feb 6;14:3000. |
dc.identifier.issn | 2045-2322 |
dc.identifier.uri | https://hdl.handle.net/11351/11079 |
dc.description | Associació de tot el genoma; Supervivència; COVID-19 |
dc.description.sponsorship | Istituto Buddista Italiano Soka Gakkai funded A.R.’s and F.C.’s project “PAT-COVID: Host genetics and pathogenetic mechanisms of COVID-19” with the 8 × 1000 funds (ID n. 2020-226 2016_RIC_3), that, in part, included the present study. We also thank the generous contribution of Banca Intesa San Paolo to R.A. The funding organisations had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript. |
dc.language.iso | eng |
dc.publisher | Nature Portfolio |
dc.relation.ispartofseries | Scientific Reports;14 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | COVID-19 (Malaltia) - Mortalitat |
dc.subject | COVID-19 (Malaltia) - Aspectes genètics |
dc.subject | Genoma humà |
dc.subject.mesh | Coronavirus Infections |
dc.subject.mesh | Genome-Wide Association Study |
dc.subject.mesh | Genetic Predisposition to Disease |
dc.title | A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1038/s41598-024-53310-x |
dc.subject.decs | infecciones por Coronavirus |
dc.subject.decs | estudio de asociación genómica completa |
dc.subject.decs | predisposición genética a la enfermedad |
dc.relation.publishversion | https://doi.org/10.1038/s41598-024-53310-x |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Minnai F] Institute of Biomedical Technologies, National Research Council, Segrate, MI, Italy. Department of Medical Biotechnology and Translational Medicine (BioMeTra), Università degli Studi di Milano, Milan, Italy. [Biscarini F] Institute of Agricultural Biology and Biotechnology, National Research Council, Milan, Italy. [Esposito M] Institute of Biomedical Technologies, National Research Council, Segrate, MI, Italy. [Dragani TA] Aspidia S.R.L., Milan, Italy. [Bujanda L] Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Biodonostia Health Research Institute, Universidad del País Vasco (UPV/EHU), San Sebastián, Spain. [Rahmouni S] GIGA Medical Genomics Unit, Uliege, Liege, Belgium. [Buti M] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain |
dc.identifier.pmid | 38321133 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |